Teva Pharmaceutical Industries Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40010012

Informations générales

Localisation

Israel

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

12/01/2023

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%

2015 (année de référence)2030

Description complète des objectifs

Teva Pharmaceutical Industries Ltd. commits to reduce absolute scope 1 and 2 GHG emissions by 46.2% by 2030 from a 2019 base year.* Teva also commits to reduce absolute scope 3 GHG emissions 25% by 2030 from a 2020 base year. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

IL0006290147

LEI

549300BAFGM4RC74ZJ94

Source : Science Based Targets initiative | Données publiques